CN Patent
CN107531742A — 奥贝胆酸的组合物和使用方法
Assigned to Intercept Pharmaceuticals Inc · Expires 2018-01-02 · 8y expired
What this patent protects
本披露涉及具有改进的稳定性、溶出度、和/或溶解度的奥贝胆酸配制品,对其制备以便使用的方法以及治疗多种疾病和病症的方法。
USPTO Abstract
本披露涉及具有改进的稳定性、溶出度、和/或溶解度的奥贝胆酸配制品,对其制备以便使用的方法以及治疗多种疾病和病症的方法。
Drugs covered by this patent
- Ocaliva (OBETICHOLIC ACID) · Intercept Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.